We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$701K
Cap. Flow
-$16.4M
Cap. Flow %
-8.91%
Top 10 Hldgs %
51.23%
Holding
107
New
12
Increased
18
Reduced
32
Closed
25

Top Buys

Rank Stock Value
1
RVNC
Revance Therapeutics, Inc.
RVNC
+$1.89M
2
BABA icon
Alibaba
BABA
+$1.31M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.09M
4
LFCR icon
Lifecore Biomedical
LFCR
+$965K
5
YETI icon
Yeti Holdings
YETI
+$443K

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$2.33M
2
ABBV icon
AbbVie
ABBV
+$1.75M
3
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$1.28M
4
T icon
AT&T
T
+$1M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$986K

Sector Composition

Rank Sector Weight
1 Healthcare 32.01%
2 Technology 17.2%
3 Communication Services 6.8%
4 Consumer Discretionary 4.09%
5 Financials 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PYPL icon
51
PayPal
PYPL
$48.9B
$676K 0.37%
11,000
-2,500
-19% -$143K
GDX icon
52
VanEck Gold Miners ETF
GDX
$22.7B
$667K 0.36%
21,500
+11,000
+105% +$322K
PFE icon
53
Pfizer
PFE
$143B
$619K 0.34%
21,500
-17,000
-44% -$514K
EVO icon
54
Evotec
EVO
$679M
$561K 0.3%
47,797
-1,250
-3% -$12.3K
SNY icon
55
Sanofi
SNY
$103B
$547K 0.3%
11,000
+1,100
+11% +$53.8K
BA icon
56
Boeing
BA
$171B
$521K 0.28%
2,000
– –
GDXJ icon
57
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
$519K 0.28%
13,700
-36,300
-73% -$1.28M
YETI icon
58
Yeti Holdings
YETI
$3.71B
$518K 0.28%
+10,000
New +$443K
EEM icon
59
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$503K 0.27%
12,500
– –
IMGN
60
DELISTED
Immunogen Inc
IMGN
$415K 0.23%
14,000
+1,150
+9% +$22.9K
TEVA icon
61
Teva Pharmaceuticals
TEVA
$40.8B
$407K 0.22%
39,000
-5,500
-12% -$51.4K
LRCX icon
62
Lam Research
LRCX
$367B
$392K 0.21%
5,000
– –
GDX icon
63
CALL
VanEck Gold Miners ETF
GDX
$22.7B
$388K 0.21%
+12,500
New +$366K
SPOT icon
64
Spotify
SPOT
$103B
$376K 0.2%
2,000
– –
C icon
65
Citigroup
C
$222B
$373K 0.2%
7,250
– –
WOLF icon
66
Wolfspeed
WOLF
$1.23B
$326K 0.18%
7,500
-6,500
-46% -$236K
TDOC icon
67
CALL
Teladoc Health
TDOC
$1.22B
$323K 0.18%
+15,000
New +$277K
ALNY icon
68
Alnylam Pharmaceuticals
ALNY
$27.5B
$249K 0.14%
1,300
-500
-28% -$85.2K
JNJ icon
69
Johnson & Johnson
JNJ
$618B
$235K 0.13%
1,500
– –
RBLX icon
70
Roblox
RBLX
$25.4B
$229K 0.12%
+5,000
New +$185K
VRDN icon
71
Viridian Therapeutics
VRDN
$2.09B
$207K 0.11%
9,500
-4,000
-30% -$63.1K
NOK icon
72
Nokia
NOK
$51B
$171K 0.09%
50,000
-121,500
-71% -$413K
LCTX icon
73
Lineage Cell Therapeutics
LCTX
$269M
$103K 0.06%
94,751
+12,000
+15% +$13.1K
BABA icon
74
CALL
Alibaba
BABA
$293B
$93K 0.05%
1,200
-23,800
-95% -$1.9M
TBHC
75
DELISTED
The Brand House Collective
TBHC
$76.8K 0.04%
25,415
-9,820
-28% -$21.5K
1 2
3
4 5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, DCF Advisers held 107 positions worth $184M, up 0.38% from $184M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

DCF Advisers withdrew a net $16.4M in Q4 2023, closing 25 positions and reducing 32 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $2.33M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in Yeti Holdings worth $518K.

  • DCF Advisers's largest Q4 2023 buy was Yeti Holdings: 10,000 shares worth $518K.
  • DCF Advisers added most to Revance Therapeutics, Inc. in Q4 2023, an estimated $1.89M increase.
  • DCF Advisers's biggest Q4 2023 reduction was AbbVie, cutting an estimated $1.75M.
  • DCF Advisers fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $2.33M.
  • DCF Advisers's ten largest holdings make up 51% of its $184M portfolio in Q4 2023.
  • DCF Advisers opened 12 new positions and closed 25 in Q4 2023.
  • DCF Advisers's portfolio value rose 0.38% quarter-over-quarter to $184M.

Based on DCF Advisers's 13F filing for Q4 2023, filed 13 Feb 2024.